ICM

Venture Capital
PORTFOLIO

Industry : Bio R&D for gene therapy

Investment Year : 2017
Investment Type : Early Stage Financing

Stonebridge Ventures places high value to unique approach to osteoarthritis, its secured patent and outstanding R&D members of ICM, and proceeded with Series B investment in the firm.

ICM is a  gene theraphy R&D company for osteoarthritis and age-related mascular disease 

Stonebridge Ventures places high value to unique approach to osteoarthritis, its secured patent and outstanding R&D members of ICM, and proceeded with Series B investment in the firm.

Gene therapy of ICM is primary for degenerative diseases  like osteoarthritis and mascular disease , so succeed of ICM’s approach liberated  the aged from their age-related suffering

ICM try to finish IND-profiling within 2018 ,and proceed clinical trial